Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
Ensysce Biosciences reports 2022 executive compensation
By ExecPay News
Published: July 13, 2023
Ensysce Biosciences reported fiscal year 2022 executive compensation information on July 13, 2023.
In 2022, three executives at Ensysce Biosciences received on average a compensation package of $590K, a 150% increase compared to previous year.
Average pay of disclosed executives at Ensysce Biosciences
David Humphrey, Chief Financial Officer, received $781K in total, which increased by 175% compared to 2021. 56% of Humphrey's compensation, or $439K, was in option awards. Humphrey also received $328K in salary and $14K in other compensation.
Lynn Kirkpatrick, Chief Executive Officer, received a compensation package of $623K, which increased by 116% compared to previous year. 63% of the compensation package, or $393K, was in salary.
Geoff Birkett, Chief Commercial Officer, earned $367K in 2022, a 172% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on July 13, 2023.